
Abstract
Objectives
To identify a critical cardiopulmonary bypass (CPB) duration threshold predictive of a complicated postoperative course after elective cardiac surgery in the absence of technical complications and to find early postoperative predictors within the high-risk group.
Design
Single-center retrospective cohort study.
Setting
An urban teaching hospital.
Participants
A total of 150 adults undergoing elective cardiac surgery with CPB. Patients with intraoperative technical surgical complications were excluded.
Interventions
Not applicable (standard clinical care).
Measurements and Main Results
A combined endpoint (in-hospital mortality; prolonged mechanical ventilation >12 hours; renal replacement therapy; neurologic complications: confusion, delirium, obtundation; requirement for norepinephrine >24 hours) defined an unfavorable postoperative course. Receiver operating characteristic curve analysis identified a CPB duration of ≥132 minutes as a specific (93%) predictor of the endpoint. Within this prolonged CPB cohort (n = 35), patients who developed complications had significantly higher immediate post-CPB leukocyte counts and lactate levels. The product of these values (Lactate × Leukocytes, in 10⁹ × mmol × L–2) demonstrated high prognostic utility. A threshold of ≥72 × 10⁹ × mmol × L–2 predicted the combined endpoint with an area under the curve of 0.909 (sensitivity 100%, specificity 81%) and strongly correlated with the duration of postoperative mechanical ventilation (rho = 0.86, p < 0.0001).
Conclusions
In the absence of technical surgical complications, a CPB duration ≥132 minutes signifies increased risk. For these patients, the simple product of immediate post-CPB lactate and leukocyte count is a powerful, readily available early predictor of a complicated postoperative course, potentially outperforming CPB duration alone and reflecting the combined pathophysiology of systemic inflammation and impaired perfusion.
We use cookies to provide you with the best possible user experience. By continuing to use our site, you agree to their use. Learn more